RBC Capital maintains Outperform rating on Insmed amid CFO change
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| INSMED (NASDAQ: INSM) | Delayed: 94.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $94.04 | 52 Week High | $19.30 | |||
| Open | $94.04 | 52 Week Low | $9.02 | |||
| Day High | $94.04 | P/E | N/A | |||
| Day Low | $94.04 | EPS | $-1.69 | |||
| Volume | 1,374 | |||||
